JAC Advance Access originally published online on May 25, 2007
Journal of Antimicrobial Chemotherapy 2007 60(1):1; doi:10.1093/jac/dkm149
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Editorial |
Funding and transparency
JAC Editorial Office, 11 The Wharf, 16 Bridge Street, Birmingham B1 2JS, UK
* Corresponding author. Tel: +44-121-633-0415; Fax: +44-121-643-9497; E-mail: jac@bsac.org.uk
| The first 10% of the full text of this article appears below. |
Since January 2006 it has been a condition for submission to the Journal of Antimicrobial Chemotherapy that authors include Transparency declarations in their articles. The function of the Transparency declarations section is to compel authors to consider any conflicts of interest that they might have, particularly those of a financial nature, and to state them so that they are evident
Transparency declarations